Agriculture
September 26, 2024
Cardio-Pad
Read SolutionImplemented by
Himore Medical
Updated on March 1, 2024
·Created on June 14, 2016
The Bilisense Jaundice Treatment Pad is a therapeutic light-emitting pad for low-cost and mobile treatment of neonatal jaundice. As of June 2019, this product is no longer featured on the manufacturer's website and appears to be discontinued.
The Bilisense Jaundice Treatment Pad is a maintenance-free solution for low-cost and mobile treatment of neonatal jaundice. The soft and flexible BilisenseTM therapeutic pad emits light in the recommended spectrum and of optimal intensity to treat neonatal hyperbilirubinemiaInterview with representative. This product is a prototype.
As of June 2019, this product is no longer featured on the manufacturer’s website and appears to be discontinued.
Target SDGs
SDG 3: Good Health and Well-Being
Market Suggested Retail Price
$300.00
Target Users (Target Impact Group)
Small and Medium-sized Enterprises, Public Sector Agencies, NGOs
Distributors / Implementing Organizations
None available, as the product is discontinued
Competitive Landscape
Direct competitors include D-Rev Brilliance Pro and Brilliance Phototherapy Device.
Manufacturing/Building Method
None available, as this product is a prototype. Large-scale manufacturing has not been initiated, product seems discontinued.
Intellectural Property Type
Patent
User Provision Model
None available.
Distributions to Date Status
None.
Average spectral irradiance (μW/cm2/nm)
?30?W/cm2/nmInterview with representative
Device dimensions
28cm x 14cm x 0.5cm (11” x 5½” x ¼”)
Device weight (kg)
0.07 kg
Effective surface area (cm)
Unknown
Illumination source
Light source embedded within treatment pad.
Irradiance uniformity ratio
Unknown
Lamp duration (hrs)
Lamp duration equivalent to lifecycle of product, which has been calculated as 5 years considering 50% utilization.
Max power consumption (W)
2.5 W
Peak wavelength (nm)
Unknown
Recommended treatment distance (cm)
Unknown, though baby is placed on top of the treatment pad.
Time totalizer (machine run/therapy)
Unknown
Voltage type
Unknown
Design Specifications
Specifications are as followsInterview with representative: Dimensions: 28cm x 14cm x 0.5cm (11” x 5½” x ¼”) Replaceable parts: None Power consumption: 1.5W (nominal), 2.5W (max) HS Code: 9018.90.84 Light intensity (APP recommended): ?30?W/cm2/nm Weight of pad: 70g (2½ oz.) Weight of power supply: 200g (7 oz.)
Technical Support
The product is meant to be used without required training or periodic maintenanceInterview with representative.
Replacement Components
The light source for the Bilisense Treatment Pad is meant to last the lifetime of the product, with no light bulbs needing to be replaced or outputs adjusted. A rechargeable battery pack is under development and estimated to be available in 2017 that will allow continued use for up to 12 hours without mains electricity, allowing mobility and making the blanket suitable for rural areas with no or unreliable mains supplyInterview with representative.
Lifecycle
Lifecycle of up to 5 years, shelf life of 10 yearsInterview with representative.
Manufacturer Specified Performance Parameters
Portable, low-cost, safe, maintenance-free, minimal training, compatible in numerous healthcare environmentsInterview with representative
Vetted Performance Status
Extensive testing and development over the course of multiple years by both the manufacturer and hospitalsInterview with representative.
Safety
Expert advisors advise the need of skilled supervision to follow the AAP guidelines that recommends evaluating response after 8 hours to see if Phototherapy device is effective, if not alternate treatment would be needed to avoid any health risks for neonates. Also they suggest that risk analysis for use / abuse conditions are needed.
Complementary Technical Systems
Can be used with disposable hygiene control sleeves and overhead phototherapy systems for additional coverageInterview with representative.
Academic Research and References
None
Compliance with regulations
This product has a CE mark and conforms to the following EU DirectivesInterview with representative: MDD 93/42/EEC (Medical Device Directive Class I device) EN 60601-1 (Medical Electrical Equipment) EN 60601-2-50 (Infant Phototherapy Equipment) EN 60601-1-2 (Collateral Standard) 2004/108/EC (Electromagnetic) 2006/95/EC (Low Voltage)
Evaluation methods
Testing by the manufacturer, clinical tests in hospitals. This product has been tested by the manufacturer to meet regulations and deemed safe by hospitals that have tested the product (Interview with representative)
Other Information
Expert advisers agree that portability is a plus for this product. They also question if there is a use case for phototherapy in non-clinical settings/resource limited scenarios since there is a need of skilled supervision. AAP guidelines recommends evaluating response after 8 hours to see if Phototherapy device is effective, if not alternate treatment would be needed.
Agriculture
September 26, 2024
Implemented by
Himore Medical
Agriculture
February 21, 2024
Implemented by
Inteco
Agriculture
January 11, 2024
Implemented by
BORDA
Agriculture
January 16, 2024
Implemented by
George Greene III, PE, PhD
Agriculture
December 27, 2023
Implemented by
Appropriate Energy Saving Technologies Limited (AEST)
Agriculture
February 5, 2024
Implemented by
Centre for Vision in the Developing World
Agriculture
February 20, 2024
Implemented by
Intellectual Ventures Lab
Agriculture
June 3, 2024
Implemented by
Dimagi
Agriculture
March 10, 2024
Implemented by
Disease Diagnostic Group
Agriculture
September 27, 2024
Implemented by
Diamedica
Have thoughts on how we can improve?
Give Us Feedback